Cellect Biotech skyrockets after receiving 'intention to grant' patents

Quoin Pharmaceuticals

07/01/2020 13:32

** U.S.-listed shares of Israel-based stem cell therapy
developer  APOP.O  more than triple premarket; set for best day
ever and highest open in 11 months at $7.68
    ** Co says European Patent Office and Israeli Intellectual
Property Office intend to grant patents to APOP for a method of
producing stem cells more quickly  urn:newsml:reuters.com:*:nPn7vV6D4a
    ** Also says patented method will produce stem cells that
are transplanted more effectively
    ** More than 925k shares traded, 31.8x its 25-DMA
    ** In 2019, co's stock had fallen 78.9%

 (Reporting by Ruhi Soni in Bengaluru)
 ((Ruhi.Soni@thomsonreuters.com;))